排序方式:
日期(降序)
日期(升序)
標題(降序)
標題(升序)
WOS引用數(降序)
WOS引用數(升序)
1.Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study
Qin, SX, Cheng, FWT,
More...
Qin, SX, Cheng, FWT, Kwok, WC, Fung, LWY, Ma, TT, Yiu, HHE, Bloom, C, Mcdonald, CF, Cheung, CL, Lai, FTT, Chui, CSL, Li, X, Wong, CKH, Wan, EYF, Wong, ICK, Chan, EWY
Less
DRUG SAFETY[0114-5916],
Published 2024,
Volume 47,
Issue 2,
Pages 135-146
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 2
2023影響因子:
4.0
2.Real-World Effectiveness and Safety of Tixagevimab–Cilgavimab: A Target Trial Emulation Study
Yan, Vincent Ka Chun
More...
Yan, Vincent Ka Chun, Yang, Yu, Wan, Eric Yuk Fai, Lai, Francisco Tsz Tsun, Chui, Celine Sze Ling, Li, Xue, Wong, Carlos King Ho, Hung, Ivan Fan Ngai, Lau, Chak Sing, Wong, Ian Chi Kei, Chan, Esther Wai Yin
Less
Drug Safety[0114-5916],
Published 2024,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 0
2023影響因子:
4.0
3.Levothyroxine Treatment Among Pregnant Women and Risk of Seizure in Children: A Population-Based Cohort Study
Ge, GM, Man, KKC, Ch
More...
Ge, GM, Man, KKC, Cheung, ECL, Ip, P, Leung, WC, Kung, AWC, Cheung, C, Wong, ICK
Less
DRUG SAFETY[0114-5916],
Published 2023,
Volume 46,
Issue 11,
Pages 1149-1159
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 0
2023影響因子:
4.0
发表年影響因子:
4.0
4.mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
Wan, EYF, Chui, CSL,
More...
Wan, EYF, Chui, CSL, Mok, AHY, Xu, WC, Yan, VKC, Lai, FTT, Li, X, Wong, CKH, Chan, EWY, Lui, DTW, Tan, KCB, Hung, IFN, Lam, CLK, Leung, GM, Wong, ICK
Less
DRUG SAFETY[0114-5916],
Published 2022,
Volume 45,
Issue 12,
Pages 1477-1490
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 10
2023影響因子:
4.0
发表年影響因子:
4.2
5.Inconsistent Safety Outcome Reporting in Randomized Clinical Trials of COVID-19 Vaccines Complicates Informed Medical Decisions
Blais, JE, Wei, Y, C
More...
Blais, JE, Wei, Y, Chui, CSL, Chan, ESW, Wong, ICK
Less
DRUG SAFETY[0114-5916],
Published 2021,
Volume 44,
Issue 11,
Pages 1121-1123
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 3
2023影響因子:
4.0
发表年影響因子:
5.228
6.Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent
Okoli, GN, Myles, P,
More...
Okoli, GN, Myles, P, Murray-Thomas, T, Shepherd, H, Wong, ICK, Edwards, D
Less
DRUG SAFETY[0114-5916],
Published 2021,
Volume 44,
Issue 10,
Pages 1033-1040
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 7
2023影響因子:
4.0
发表年影響因子:
5.228
7.Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study
Li, X, Pathadka, S,
More...
Li, X, Pathadka, S, Man, KKC, Ng, VWS, Siu, CW, Wong, ICK, Chan, EW, Lau, WCY
Less
DRUG SAFETY[0114-5916],
Published 2020,
Volume 43,
Issue 10,
Pages 1023-1033
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 9
2023影響因子:
4.0
发表年影響因子:
5.606
8.Patterns of Inpatient Antibiotic Use Among Public Hospitals in Hong Kong from 2000 to 2015
Chui, CSL, Cowling,
More...
Chui, CSL, Cowling, BJ, Lim, WW, Hui, CKM, Chan, EHW, Wong, ICK, Wu, P
Less
DRUG SAFETY[0114-5916],
Published 2020,
Volume 43,
Issue 6,
Pages 595-606
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 5
2023影響因子:
4.0
发表年影響因子:
5.606
9.Prevalence, Safety and Long-Term Retention Rates of Biologics in Hong Kong from 2001 to 2015
Ge, MQ, Man, KK, Chu
More...
Ge, MQ, Man, KK, Chui, CS, Chan, EW, Wong, IC, Li, X
Less
DRUG SAFETY[0114-5916],
Published 2019,
Volume 42,
Issue 9,
Pages 1091-1102
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 1
2023影響因子:
4.0
发表年影響因子:
3.442
10.Advances in Epidemiological Methods and Utilisation of Large Databases: A Methodological Review of Observational Studies on Central Nervous System Drug Use in Pregnancy and Central Nervous System Outcomes in Children
Wang, ZX, Ho, PWH, C
More...
Wang, ZX, Ho, PWH, Choy, MTH, Wong, ICK, Brauer, R, Man, KKC
Less
DRUG SAFETY[0114-5916],
Published 2019,
Volume 42,
Issue 4,
Pages 499-513
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 12
2023影響因子:
4.0
发表年影響因子:
3.442
11.Neuropsychiatric Events Associated with Leukotriene-Modifying Agents: A Systematic Review
Law, SWY, Wong, AYS,
More...
Law, SWY, Wong, AYS, Anand, S, Wong, ICK, Chan, EW
Less
DRUG SAFETY[0114-5916],
Published 2018,
Volume 41,
Issue 3,
Pages 253-265
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 32
2023影響因子:
4.0
发表年影響因子:
3.526
12.Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis
Wong, AYS, Chan, EW,
More...
Wong, AYS, Chan, EW, Anand, S, Worsley, AJ, Wong, ICK
Less
DRUG SAFETY[0114-5916],
Published 2017,
Volume 40,
Issue 8,
Pages 663-677
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 31
2023影響因子:
4.0
发表年影響因子:
3.643
13.The New Phase of ISoP
Olsson, Sten, Wong,
More...
Olsson, Sten, Wong, Ian C.K., Delumeau, Jean Christophe, Harrison-Woolrych, Mira
Less
Drug Safety[0114-5916],
Published 2017,
Volume 40,
Issue 10,
Pages 841-844
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 1
2023影響因子:
4.0
发表年影響因子:
3.643
14.Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries
Roughead, EE, Chan,
More...
Roughead, EE, Chan, EW, Choi, NK, Kimura, M, Kimura, T, Kubota, K, Lai, ECC, Man, KKC, Nguyen, TA, Ooba, N, Park, BJ, Sato, T, Shin, JY, Wang, TT, Griffiths, J, Wong, ICK, Yang, YHK, Pratt, NL
Less
DRUG SAFETY[0114-5916],
Published 2015,
Volume 38,
Issue 9,
Pages 823-831
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 31
2023影響因子:
4.0
发表年影響因子:
3.206
15.Pediatric Drug Safety Signal Detection: A New Drug-Event Reference Set for Performance Testing of Data-Mining Methods and Systems
Osokogu, OU, Fregone
More...
Osokogu, OU, Fregonese, F, Ferrajolo, C, Verhamme, K, de Bie, S, 't Jong, G, Catapano, M, Weibel, D, Kaguelidou, F, Bramer, WM, Hsia, Y, Wong, ICK, Gazarian, M, Bonhoeffer, J, Sturkenboom, M
Less
DRUG SAFETY[0114-5916],
Published 2015,
Volume 38,
Issue 2,
Pages 207-217
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 15
2023影響因子:
4.0
发表年影響因子:
3.206
16.Feasibility of Pharmacist- Participated Anticoagulation Management Service (PAMS) in A Regional Hospital in Shanghai: A Pilot Study
Liu, KQL, Lu, HP, Go
More...
Liu, KQL, Lu, HP, Gong, JR, Wong, ICK, Chan, EWY
Less
DRUG SAFETY[0114-5916],
Published 2014,
Volume 37,
Issue 10,
Pages 878-878
收錄情况:
WOS
WOS核心合集引用: 1
2023影響因子:
4.0
发表年影響因子:
2.824
17.The Unmet Needs of Antithrombotic Treatment in Patients with Non-Valvular Atrial Fibrillation in Real-World Clinical Practice
Lau, WCY, Chan, EW,
More...
Lau, WCY, Chan, EW, Liu, K, Wong, ICK
Less
DRUG SAFETY[0114-5916],
Published 2014,
Volume 37,
Issue 10,
Pages 854-854
收錄情况:
WOS
WOS核心合集引用: 0
2023影響因子:
4.0
发表年影響因子:
2.824
18.The Association between Oral Fluoroquinolone use and the Development of Retinal Detachment: A Systematic Review and Meta-analysis of Observational Studies
Chui, CSL, Wong, ICK
More...
Chui, CSL, Wong, ICK, Wong, LYL, Chan, EW
Less
DRUG SAFETY[0114-5916],
Published 2014,
Volume 37,
Issue 10,
Pages 852-852
收錄情况:
WOS
WOS核心合集引用: 0
2023影響因子:
4.0
发表年影響因子:
2.824
19.Selective Serotonin Reuptake Inhibitor Exposure during Pregnancy and Risk of Autism Spectrum Disorders in Children: A Meta-Analysis of Observational Studies
Tong, HHY, Man, KKC,
More...
Tong, HHY, Man, KKC, Chan, EW, Wong, LYL, Wong, ICK
Less
DRUG SAFETY[0114-5916],
Published 2014,
Volume 37,
Issue 10,
Pages 836-836
收錄情况:
WOS
WOS核心合集引用: 0
2023影響因子:
4.0
发表年影響因子:
2.824
20.Effects of Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder on Trauma Related Accident and Emergency Admissions: Self-Controlled Case Series Study
Man, KKC, Chan, EW,
More...
Man, KKC, Chan, EW, Coghill, DR, Douglas, IJ, Ip, P, Leung, LP, Tsui, MSH, Wong, WHS, Wong, ICK
Less
DRUG SAFETY[0114-5916],
Published 2014,
Volume 37,
Issue 10,
Pages 834-834
收錄情况:
WOS
WOS核心合集引用: 0
2023影響因子:
4.0
发表年影響因子:
2.824